Abstract
Beta (B.1.351)-variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19-related death were 1.24-fold (1.11-1.39), 1.49-fold (1.13-1.97), and 1.57-fold (1.03-2.43) higher, respectively, for the Beta variant.
Keywords: SARS-CoV-2; epidemiology; infection; severe disease; variant.
All Keywords
【저자키워드】 SARS-CoV-2, Epidemiology, variant, Infection, severe disease, 【초록키워드】 COVID-19, coronavirus disease, Coronavirus disease 2019, B.1.351, variant, B.1.1.7, Alpha, Beta, Beta variant, disease, Critical disease, severe disease, 95% confidence interval, COVID-19-related death, investigated, 【제목키워드】 coronavirus 2, respiratory,
【저자키워드】 SARS-CoV-2, Epidemiology, variant, Infection, severe disease, 【초록키워드】 COVID-19, coronavirus disease, Coronavirus disease 2019, B.1.351, variant, B.1.1.7, Alpha, Beta, Beta variant, disease, Critical disease, severe disease, 95% confidence interval, COVID-19-related death, investigated, 【제목키워드】 coronavirus 2, respiratory,
{{{ 추상적인 }}}
베타(B.1.351)-변형 코로나바이러스 질병 2019(COVID-19) 질병이 카타르에서 조사되었습니다. 알파(B.1.1.7) 변이체와 비교했을 때 중증, 중환자, 코로나19 관련 사망으로 진행될 확률(95% 신뢰구간)은 1.24배(1.11~1.39), 1.49배(1.49배)였다. 베타 변형의 경우 각각 1.13-1.97) 및 1.57배(1.03-2.43) 높습니다.
{{ 키워드: }} SARS-CoV-2; 역학; 전염병; 심각한 질병; 변종.